Evidence map›Paper›PMID 36717837›Full record

ArticleBMC pharmacology & toxicology2023

Glycyrrhetinic acid protects against Multidrug-resistant Acinetobacter baumannii-induced lung epithelial cells injury by regulating inflammation and oxidative stress.

Piaoyi Guo, Liang Jin, Huifen Zhou, Yida Bao, Jiehong Yang, Jing Chen, Yu He, Daojun Yu, Haitong Wan

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Amygdalin Reverses Macrophage PANoptosis Induced by Drug-ResistantJournal of microbiology and biotechnology · 2023
    Article
  3. Protective Effects of Rhamnetin in Carbapenem-ResistantInternational journal of molecular sciences · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Piaoyi Guo *Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Liang Jin *Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Huifen ZhouZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Yida BaoZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Jiehong YangZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Jing ChenZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Yu HeZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China.
Daojun YuAffiliated Hangzhou First People's Hospital, Zhejiang University of Medicine, Hangzhou, Zhejiang, 310003, PR China. yudaojun98@163.com.
Haitong WanZhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, PR China. whtong@126.com.
Zhejiang Chinese Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycyrrhetinic acid (GA) is a bio-effective component of Licorice. The GA is a monomer and the ingredient is an Oleanane-type pentacyclic triterpenes that has been used as a remedy for years. Due to the abuse of antibiotics, people pay attention to the emergence of Multidrug-resistant Acinetobacter baumannii (MDR-AB). As a conditional pathogen, MDR-AB causes severe infection, endangering human lives. Our previous studies found GA played an important role in Yinhua Pinggan, a Chinese medicine. However, whether GA could protect lung epithelium from MDR-AB-induced cell injury was elusive. Herein, we investigated the effects of GA on MDR-AB-infected A549 cells. The results showed GA had slightly antibacterial activity to MDR-AB in the GA (high concentration) but no impact on drug resistance genes. Notwithstanding, GA could reverse MDR-AB-induced cell apoptosis, hampered adhesion and invasion of MDR-AB to cells, and inhibit pro-inflammatory cytokines expression of IL-1β, IL-6, and TNF. Besides, MDR-AB-induced reactive oxygen species, pro-oxidative protein malonaldehyde, and myeloperoxidase of cells were decreased by GA, while antioxidative proteins were recovered, showing antioxidative capacity of GA might play a critical role. The expressions of toll-like receptor (TLRs) - 1, 2, 4, 5, 6, and 9 were increased by MDR-AB infection, while GA reversed the tendency. Interestingly, GA inhibited MDR-AB induced myeloiddifferentiationfactor88 expression (MYD88), one downstream con-factors of TLRs, but no affection on Interferon regulatory Factor 3 (IRF3), the other one, indicating GA inhibited MDR-AB induced cell injury by impact TLR/MYD88 pathway to attenuate inflammation. Altogether, our results demonstrated that GA protects against MDR-AB-induced cell injury through its antioxidative and anti-inflammatory properties, which deserve further study in the future.

Indexed as

Acinetobacter baumanniiGlycyrrhetinic AcidAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialEpithelial CellsHumansInflammationLungMyeloid Differentiation Factor 88Oxidative StressAnti-Bacterial AgentsGlycyrrhetinic AcidMyeloid Differentiation Factor 88AntioxidantCell infectionGlycyrrhetinic acidInflammationMeropenemMultidrug-resistant Acinetobacter baumannii

Identifiers

PMID36717837
PMCPMC9887834
OpenAlexW4318484077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.